635 related articles for article (PubMed ID: 9621512)
1. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
[TBL] [Abstract][Full Text] [Related]
2. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
3. Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.
Mitsubuchi H; Nobukuni Y; Akaboshi I; Indo Y; Endo F; Matsuda I
J Clin Invest; 1991 Apr; 87(4):1207-11. PubMed ID: 2010537
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
[TBL] [Abstract][Full Text] [Related]
5. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Yoshioka A; Matsuda I
J Clin Invest; 1991 May; 87(5):1862-6. PubMed ID: 2022752
[TBL] [Abstract][Full Text] [Related]
6. Maple syrup urine disease. Complete primary structure of the E1 beta subunit of human branched chain alpha-ketoacid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease.
Nobukuni Y; Mitsubuchi H; Endo F; Akaboshi I; Asaka J; Matsuda I
J Clin Invest; 1990 Jul; 86(1):242-7. PubMed ID: 2365818
[TBL] [Abstract][Full Text] [Related]
7. [Gene analysis of maple syrup urine disease (MSUD)].
Mitsubuchi H; Nobukuni Y; Hayashida Y; Ohta K; Indo Y; Akaboshi I; Endo F; Matsuda I
Rinsho Byori; 1993 May; 41(5):484-91. PubMed ID: 8350511
[TBL] [Abstract][Full Text] [Related]
8. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
Dennis JA; Healy PJ
Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
[TBL] [Abstract][Full Text] [Related]
9. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
Chuang JL; Cox RP; Chuang DT
J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
[TBL] [Abstract][Full Text] [Related]
10. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
[TBL] [Abstract][Full Text] [Related]
11. Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.
Indo Y; Kitano A; Endo F; Akaboshi I; Matsuda I
J Clin Invest; 1987 Jul; 80(1):63-70. PubMed ID: 3597778
[TBL] [Abstract][Full Text] [Related]
12. Molecular defects in the E1 alpha subunit of the branched-chain alpha-ketoacid dehydrogenase complex that cause maple syrup urine disease.
Zhang B; Zhao Y; Harris RA; Crabb DW
Mol Biol Med; 1991 Feb; 8(1):39-47. PubMed ID: 1943689
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of maple syrup urine disease in the Turkish population.
Gorzelany K; Dursun A; Coşkun T; Kalkanoğlu-Sivri SH; Gökçay GF; Demirkol M; Feyen O; Wendel U
Turk J Pediatr; 2009; 51(2):97-102. PubMed ID: 19480318
[TBL] [Abstract][Full Text] [Related]
14. Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease.
Henneke M; Flaschker N; Helbling C; Müller M; Schadewaldt P; Gärtner J; Wendel U
Hum Mutat; 2003 Nov; 22(5):417. PubMed ID: 14517957
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the E1 beta subunit in the branched-chain alpha-keto acid dehydrogenase complex due to a single base substitution of the intron 5, resulting in two alternatively spliced mRNAs in a patient with maple syrup urine disease.
Hayashida Y; Mitsubuchi H; Indo Y; Ohta K; Endo F; Wada Y; Matsuda I
Biochim Biophys Acta; 1994 Feb; 1225(3):317-25. PubMed ID: 8312380
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.
Fisher CW; Fisher CR; Chuang JL; Lau KS; Chuang DT; Cox RP
Am J Hum Genet; 1993 Feb; 52(2):414-24. PubMed ID: 8430702
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency.
Odièvre MH; Chretien D; Munnich A; Robinson BH; Dumoulin R; Masmoudi S; Kadhom N; Rötig A; Rustin P; Bonnefont JP
Hum Mutat; 2005 Mar; 25(3):323-4. PubMed ID: 15712224
[TBL] [Abstract][Full Text] [Related]
18. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
19. Four novel mutations identified in Norwegian patients result in intermittent maple syrup urine disease when combined with the R301C mutation.
Brodtkorb E; Strand J; Backe PH; Lund AM; Bjørås M; Rootwelt T; Rootwelt H; Woldseth B; Eide L
Mol Genet Metab; 2010 Aug; 100(4):324-32. PubMed ID: 20570198
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease.
Ali EZ; Yunus ZM; Desa NM; Hock NL
J Pediatr Endocrinol Metab; 2013; 26(9-10):975-80. PubMed ID: 23729548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
